DOES THE HIGHER DOSE OF BETA-BLOCKER THERAPY GUARANTEE THE BETTER OUTCOME IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION?

Se Yong Jang(Kyungpook National University Hospital), Shung Chull Chae(Kyungpook National University Hospital), Chang-Yeon Kim(Kyungpook National University Hospital), Dong Heon Yang(Kyungpook National University Hospital), Yongkeun Cho(Kyungpook National University Hospital), Hun Sik Park(Kyungpook National University Hospital), Jang Hoon Lee(Chungnam National University), Nam Kyun Kim(Kyungpook National University Hospital), Myung Hwan Bae(Kyungpook National University Hospital)
Journal of the American College of Cardiology
April 1, 2016
10.1016/s0735-1097(16)30559-9
Cited by 1

Related Papers

Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
|The Lancet|2018|372
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease
|Journal of the American College of Cardiology|2010|278